Cargando…

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)

Polycystic ovary syndrome (PCOS) is the most frequent cause of female infertility. The treatment of PCOS patients with insulin sensitizers, such as metformin or thiazolidinediones, increases the ovulation rate and the number of successful pregnancies. The positive action of the insulin-sensitizing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Froment, Pascal, Touraine, Philippe
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779579/
https://www.ncbi.nlm.nih.gov/pubmed/17347533
http://dx.doi.org/10.1155/PPAR/2006/73986
_version_ 1782131809207713792
author Froment, Pascal
Touraine, Philippe
author_facet Froment, Pascal
Touraine, Philippe
author_sort Froment, Pascal
collection PubMed
description Polycystic ovary syndrome (PCOS) is the most frequent cause of female infertility. The treatment of PCOS patients with insulin sensitizers, such as metformin or thiazolidinediones, increases the ovulation rate and the number of successful pregnancies. The positive action of the insulin-sensitizing treatments could be explained by a decrease in the peripheral insulin resistance but also by a direct action at the ovarian level. We report in this review different hypotheses of thiazolidinediones actions to improve PCOS (steroid secretion by ovarian cells ; insulin sensitivity in muscle and adipocyte and fat redistribution).
format Text
id pubmed-1779579
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-17795792007-02-01 Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS) Froment, Pascal Touraine, Philippe PPAR Res Review Article Polycystic ovary syndrome (PCOS) is the most frequent cause of female infertility. The treatment of PCOS patients with insulin sensitizers, such as metformin or thiazolidinediones, increases the ovulation rate and the number of successful pregnancies. The positive action of the insulin-sensitizing treatments could be explained by a decrease in the peripheral insulin resistance but also by a direct action at the ovarian level. We report in this review different hypotheses of thiazolidinediones actions to improve PCOS (steroid secretion by ovarian cells ; insulin sensitivity in muscle and adipocyte and fat redistribution). Hindawi Publishing Corporation 2006 2006-12-14 /pmc/articles/PMC1779579/ /pubmed/17347533 http://dx.doi.org/10.1155/PPAR/2006/73986 Text en Copyright © 2006 P. Froment and P. Touraine. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Froment, Pascal
Touraine, Philippe
Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
title Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
title_full Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
title_fullStr Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
title_full_unstemmed Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
title_short Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
title_sort thiazolidinediones and fertility in polycystic ovary syndrome (pcos)
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779579/
https://www.ncbi.nlm.nih.gov/pubmed/17347533
http://dx.doi.org/10.1155/PPAR/2006/73986
work_keys_str_mv AT fromentpascal thiazolidinedionesandfertilityinpolycysticovarysyndromepcos
AT tourainephilippe thiazolidinedionesandfertilityinpolycysticovarysyndromepcos